AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29282609 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 20662329 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 18309461 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 25686857 — Biomarker: Cytochrome c
Type: Safety Biomarker (SAF)
Study 21722960 — Biomarker: Vitamin B12
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Study 7963711 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 21600550 — Biomarker: PGR mRNA
Type: Predictive Biomarker (PRD)
Genes: PGR; NR3C3
Study 8126146 — Biomarker: TBXT mRNA
Type: Predictive Biomarker (PRD)
Genes: TBXT; T
Study 25757039 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 19382463 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 19382463 — Biomarker: Myeloperoxidase
Type: Safety Biomarker (SAF)
Genes: MPO
Study 9812081 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 9812081 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8950297 — Biomarker: POMC
Type: Predictive Biomarker (PRD)
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 23469080 — Biomarker: C-X-C motif chemokine 5
Type: Safety Biomarker (SAF)
Genes: CXCL5; ENA78; SCYB5
Study 19116328 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 23290323 — Biomarker: PICALM mRNA
Type: Predictive Biomarker (PRD)
Genes: PICALM; CALM
Study 18823986 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 31096012 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 31096012 — Biomarker: SELENBP1 mRNA
Type: Predictive Biomarker (PRD)
Genes: SELENBP1; SBP
Study 31096012 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 26963592 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 23392399 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 23392399 — Biomarker: Intercellular adhesion molecule 1
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: ICAM1
Study 8865083 — Biomarker: SLC2A4 mRNA
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: SLC2A4; GLUT4
Study 22419732 — Biomarker: Dipeptidyl peptidase 4
Type: Pharmacodynamic Biomarker (PDY)
Genes: DPP4; ADCP2; CD26
Study 20595675 — Biomarker: CCS mRNA
Type: Predictive Biomarker (PRD)
Genes: CCS
Study 31915906 — Biomarker: ADRB2 mRNA
Type: Predictive Biomarker (PRD)
Genes: ADRB2; ADRB2R; B2AR
Study 23620431 — Biomarker: RPE mRNA
Type: Predictive Biomarker (PRD)
Genes: RPE; HUSSY-17
Study 22070641 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 18711172 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 11422429 — Biomarker: Nerve growth factor
Type: Predictive Biomarker (PRD)
Genes: NGF; NGFB
Study 2441633 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study 18414111 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 27402235 — Biomarker: SCD mRNA
Type: Predictive Biomarker (PRD)
Genes: SCD; FADS5; SCD1; SCDOS
Study 18840367 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 18840367 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16880243 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 28060083 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 25816110 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15140340 — Biomarker: TBXT mRNA
Type: Predictive Biomarker (PRD)
Genes: TBXT; T
Study 9419168 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 329943 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16234828 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study 10905544 — Biomarker: Coagulation factor IIa
Type: Safety Biomarker (SAF)
Genes: F2
Study 10168173 — Biomarker: Adenosine deaminase
Type: Monitoring Biomarker (MOI)
Genes: ADA; ADA1
Study 22761453 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 11434469 — Biomarker: LPL mRNA
Type: Predictive Biomarker (PRD)
Genes: LPL; LIPD
Study 28120485 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 23234813 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 17263088 — Biomarker: EP300 mRNA
Type: Predictive Biomarker (PRD)
Genes: EP300; P300
Study 9283511 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 7685921 — Biomarker: NPEPPS mRNA
Type: Predictive Biomarker (PRD)
Genes: NPEPPS; PSA
Study 29846100 — Biomarker: Epidermal growth factor receptor
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: EGFR; ERBB; ERBB1; HER1
Study 27583476 — Biomarker: MIP mRNA
Type: Predictive Biomarker (PRD)
Genes: MIP; AQP0
Study 27583476 — Biomarker: Dipeptidyl peptidase 4
Type: Pharmacodynamic Biomarker (PDY)
Genes: DPP4; ADCP2; CD26
Study 1887968 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 6693150 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 26990318 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 26990318 — Biomarker: CD46 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD46; MCP; MIC10
Study 18159246 — Biomarker: EBF1 mRNA
Type: Predictive Biomarker (PRD)
Genes: EBF1; COE1; EBF
Study 18159246 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 10689269 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 31926340 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 31413542 — Biomarker: Liver iron
Type: Predictive Biomarker (PRD)
Study 21576636 — Biomarker: Epidermal growth factor receptor
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: EGFR; ERBB; ERBB1; HER1
Study 19589270 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 19589270 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 19589270 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 16466589 — Biomarker: MCIDAS mRNA
Type: Predictive Biomarker (PRD)
Genes: MCIDAS; IDAS; MCI; MCIN
Study 22320902 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 29880873 — Biomarker: Exhaled carbon monoxide
Type: Surrogate Endpoint (SUR)
Study 23582750 — Biomarker: Apolipoprotein E
Type: Predictive Biomarker (PRD)
Genes: APOE
Study 8675576 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study 8675576 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 27986742 — Biomarker: BPI mRNA
Type: Predictive Biomarker (PRD)
Genes: BPI
Study 22370326 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 28793880 — Biomarker: Procalcitonin
Type: Monitoring Biomarker (MOI)
Study 28793880 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 23123868 — Biomarker: CP mRNA
Type: Predictive Biomarker (PRD)
Genes: CP
Study 23123868 — Biomarker: MAS1 mRNA
Type: Predictive Biomarker (PRD)
Genes: MAS1; MAS
Study 3948442 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 21189431 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 21189431 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 21189431 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 18776057 — Biomarker: CCS mRNA
Type: Predictive Biomarker (PRD)
Genes: CCS
Study 17161072 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 10660736 — Biomarker: CPA1 mRNA
Type: Predictive Biomarker (PRD)
Genes: CPA1; CPA
Study 9070555 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30475961 — Biomarker: DHCR7 mRNA
Type: Predictive Biomarker (PRD)
Genes: DHCR7; D7SR
Study 30475961 — Biomarker: CYP2R1 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP2R1
Study 30475961 — Biomarker: Vitamin D-binding protein
Type: Predictive Biomarker (PRD)
Genes: GC
Study 30475961 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 29262474 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 29262474 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16641282 — Biomarker: CXCR4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CXCR4
Study 16641282 — Biomarker: CCR5 mRNA
Type: Predictive Biomarker (PRD)
Genes: CCR5; CMKBR5
Study 11044164 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 11044164 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 6125172 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 27657352 — Biomarker: Adrenomedullin
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Genes: ADM; AM
Study 26715818 — Biomarker: ERAS mRNA
Type: Predictive Biomarker (PRD)
Genes: ERAS; HRAS2; HRASP
Study 23867982 — Biomarker: Apolipoprotein E
Type: Predictive Biomarker (PRD)
Genes: APOE
Study 23867982 — Biomarker: Estrogen receptor
Type: Predictive Biomarker (PRD)
Genes: ESR1; ESR; NR3A1
Study 16967285 — Biomarker: PVR mRNA
Type: Predictive Biomarker (PRD)
Genes: PVR; PVS
Study 2338696 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16949180 — Biomarker: 51Cr-EDTA
Type: Safety Biomarker (SAF)
Study 16338265 — Biomarker: Cyclic guanosine monophosphate
Type: Pharmacodynamic Biomarker (PDY)
Study 22626878 — Biomarker: MBP mRNA
Type: Predictive Biomarker (PRD)
Genes: MBP
Study 22626878 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 7731155 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 6626426 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 21947137 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 17453747 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 10875487 — Biomarker: Eosinophil cationic protein
Type: Safety Biomarker (SAF)
Genes: RNASE3; ECP; RNS3
Study 8257124 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 2984100 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30556961 — Biomarker: Hyaluronic acid
Type: Safety Biomarker (SAF)
Study 25369831 — Biomarker: Serum LDL cholesterol
Type: Surrogate Endpoint (SUR)
Study 25369831 — Biomarker: Estrogen receptor
Type: Predictive Biomarker (PRD)
Genes: ESR1; ESR; NR3A1
Study 25369831 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 25369831 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 14618331 — Biomarker: FES mRNA
Type: Predictive Biomarker (PRD)
Genes: FES; FPS
Study 9224079 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 7957150 — Biomarker: CAT mRNA
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: CAT
Study 28958804 — Biomarker: Cardiac troponin I
Type: Safety Biomarker (SAF)
Genes: TNNI3; TNNC1
Study 21998477 — Biomarker: Hemagglutination inhibition antibody
Type: Surrogate Endpoint (SUR)
Study 31973765 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29402848 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 26259808 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30205746 — Biomarker: TYK2 mRNA
Type: Predictive Biomarker (PRD)
Genes: TYK2
Study 21194605 — Biomarker: SV2A mRNA
Type: Predictive Biomarker (PRD)
Genes: SV2A; KIAA0736; PSEC0174
Study 17497175 — Biomarker: COMT mRNA
Type: Predictive Biomarker (PRD)
Genes: COMT
Study 12118903 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 9071195 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 3493903 — Biomarker: Adrenomedullin
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Genes: ADM; AM
Study 20546277 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 22827973 — Biomarker: Hormone receptor
Type: Predictive Biomarker (PRD)
Study 20845296 — Biomarker: Sperm parameters
Type: Surrogate Endpoint (SUR)
Study 14571302 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 14571302 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 8901790 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 30369310 — Biomarker: PAH mRNA
Type: Predictive Biomarker (PRD)
Genes: PAH
Study 11079649 — Biomarker: MB mRNA
Type: Predictive Biomarker (PRD)
Genes: MB
Study 29132482 — Biomarker: FES mRNA
Type: Predictive Biomarker (PRD)
Genes: FES; FPS
Study 22749926 — Biomarker: EP300 mRNA
Type: Predictive Biomarker (PRD)
Genes: EP300; P300
Study 22834649 — Biomarker: Serum testosterone
Type: Surrogate Endpoint (SUR)
Study 20485136 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 7437240 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 31810194 — Biomarker: TH mRNA
Type: Predictive Biomarker (PRD)
Genes: TH; TYH
Study 31810194 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 17378192 — Biomarker: SI mRNA
Type: Predictive Biomarker (PRD)
Genes: SI
Study 14647218 — Biomarker: NUCB2 mRNA
Type: Predictive Biomarker (PRD)
Genes: NUCB2; NEFA
Study 10522582 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 10522582 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 1931867 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 16798785 — Biomarker: Serum bactericidal antibody
Type: Surrogate Endpoint (SUR)
Study 9378531 — Biomarker: ABO mRNA
Type: Predictive Biomarker (PRD)
Genes: ABO
Study 9378531 — Biomarker: SLC14A1 mRNA
Type: Predictive Biomarker (PRD)
Genes: SLC14A1; HUT11; JK; RACH1; UT1; UTE
Study 23135172 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 15200045 — Biomarker: D-dimer
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Study 1773691 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 1773691 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 1773691 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 31529295 — Biomarker: MGP mRNA
Type: Predictive Biomarker (PRD)
Genes: MGP; MGLAP; GIG36
Study 22412143 — Biomarker: Erbb2 tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 7523131 — Biomarker: NPEPPS mRNA
Type: Predictive Biomarker (PRD)
Genes: NPEPPS; PSA
Study 18194800 — Biomarker: Lactate dehydrogenase
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 14566252 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 11168342 — Biomarker: Intercellular adhesion molecule 1
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: ICAM1
Study 11168342 — Biomarker: Plasminogen activator inhibitor
Type: Safety Biomarker (SAF)
Genes: SERPINE1; PAI1; PLANH1
Study 25759106 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 23843932 — Biomarker: GAD1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GAD1; GAD; GAD67
Study 2006663 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16831185 — Biomarker: Adrenomedullin
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Genes: ADM; AM
Study 27680390 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 20386344 — Biomarker: Extracellular signal-regulated kinase
Type: Pharmacodynamic Biomarker (PDY)
Study 11199863 — Biomarker: Antithrombin-III
Type: Safety Biomarker (SAF)
Genes: SERPINC1; AT3; PRO0309
Study 8329024 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 24814231 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 22858558 — Biomarker: Vascular endothelial growth factor
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 22858558 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 10397076 — Biomarker: SCD mRNA
Type: Predictive Biomarker (PRD)
Genes: SCD; FADS5; SCD1; SCDOS
Study 10397076 — Biomarker: TRH mRNA
Type: Predictive Biomarker (PRD)
Genes: TRH
Study 2582726 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30802725 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 1541312 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16037751 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 8635038 — Biomarker: EPX mRNA
Type: Predictive Biomarker (PRD)
Genes: EPX; EPER; EPO; EPP
Study 25112865 — Biomarker: Mitochondrial frataxin
Type: Monitoring Biomarker (MOI)
Genes: FXN; FRDA; X25
Study 22747998 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15640479 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 9950598 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 9950598 — Biomarker: Leukocyte surface antigen Leu-16
Type: Predictive Biomarker (PRD)
Genes: MS4A1; CD20
Study 31415381 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study 26044169 — Biomarker: TLR7 mRNA
Type: Predictive Biomarker (PRD)
Genes: TLR7; UNQ248/PRO285
Study 23432466 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 11289347 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 9923089 — Biomarker: CCK mRNA
Type: Predictive Biomarker (PRD)
Genes: CCK
Study 23770179 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 23770179 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 20185616 — Biomarker: Platelet-derived growth factor B
Type: Pharmacodynamic Biomarker (PDY)
Genes: PDGFB; PDGF2; SIS
Study 18286595 — Biomarker: L-acetylcarnitine
Type: Safety Biomarker (SAF)
Study 14583175 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 10555125 — Biomarker: Granulocyte-macrophage colony-stimulating factor
Type: Safety Biomarker (SAF)
Genes: CSF2; GMCSF
Study 17399725 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 7924325 — Biomarker: NOG mRNA
Type: Predictive Biomarker (PRD)
Genes: NOG
Study 23835594 — Biomarker: RPE mRNA
Type: Predictive Biomarker (PRD)
Genes: RPE; HUSSY-17
Study 20888653 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15363656 — Biomarker: Endothelin-1
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Genes: EDN1
Study 8127015 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 28657604 — Biomarker: GGT1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GGT1; GGT
Study 25279689 — Biomarker: White blood cell
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 27031850 — Biomarker: Angiopoietin-2
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Genes: ANGPT2
Study 11528361 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 11528361 — Biomarker: Plasminogen activator inhibitor
Type: Safety Biomarker (SAF)
Genes: SERPINE1; PAI1; PLANH1
Study 11528361 — Biomarker: Antithrombin-III
Type: Safety Biomarker (SAF)
Genes: SERPINC1; AT3; PRO0309
Study 26620248 — Biomarker: SLC5A2 mRNA
Type: Predictive Biomarker (PRD)
Genes: SLC5A2; SGLT2
Study 26620248 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 11057934 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 19102857 — Biomarker: B-type natriuretic peptide
Type: Safety Biomarker (SAF)
Genes: NPPB
Study 23252455 — Biomarker: CP mRNA
Type: Predictive Biomarker (PRD)
Genes: CP
Study 19138577 — Biomarker: HP mRNA
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: HP
Study 12622322 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 24737541 — Biomarker: Pathological complete response
Type: Surrogate Endpoint (SUR)
Study 12545143 — Biomarker: Multidrug resistance protein 1
Type: Predictive Biomarker (PRD)
Genes: ABCB1; MDR1; PGY1
Study 2581099 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 19100010 — Biomarker: PAH mRNA
Type: Predictive Biomarker (PRD)
Genes: PAH
Study 19100010 — Biomarker: Complement C3
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: C3; CPAMD1
Study 19100010 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 16371736 — Biomarker: CD14 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD14
Study 16371736 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 29504705 — Biomarker: Multidrug resistance protein 1
Type: Predictive Biomarker (PRD)
Genes: ABCB1; MDR1; PGY1
Study 27779454 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 19478674 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 11137759 — Biomarker: Microtubule-associated protein tau
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY)
Genes: MAPT; MAPTL; MTBT1; TAU
Study 3024959 — Biomarker: TRH mRNA
Type: Predictive Biomarker (PRD)
Genes: TRH
Study 31539295 — Biomarker: Epidermal growth factor receptor
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: EGFR; ERBB; ERBB1; HER1
Study 31539295 — Biomarker: Erbb2 tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31539295 — Biomarker: Proto-oncogene c-Met
Type: Predictive Biomarker (PRD)
Genes: MET
Study 31539295 — Biomarker: ALK tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ALK
Study 31539295 — Biomarker: ROS1 mRNA
Type: Predictive Biomarker (PRD)
Genes: ROS1; MCF3; ROS
Study 31539295 — Biomarker: RET mRNA
Type: Predictive Biomarker (PRD)
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 31539295 — Biomarker: Phosphatase and tensin homolog
Type: Predictive Biomarker (PRD)
Genes: PTEN; MMAC1; TEP1
Study 31539295 — Biomarker: AKT1 mRNA
Type: Predictive Biomarker (PRD)
Genes: AKT1; PKB; RAC
Study 31539295 — Biomarker: Microsatellite instability
Type: Predictive Biomarker (PRD)
Study 25029875 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16579084 — Biomarker: D-dimer
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Study 21091269 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)